Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2).

PropertyValue
has major subject area list Alzheimer Disease; Apathy; Central Nervous System Stimulants; Methylphenidate
information resource reference Lanct?t KL, Chen C, Mah E, Kiss A, Li A, Shade D, Scherer RW, Vieira D, Coulibaly H, Rosenberg PB, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer J, Herrmann N. Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2). Int Psychogeriatr. 2023 11; 35(11):664-672.
label Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2).

Search Criteria
  • Apathy